Background No adjuvant treatment has been established for patients who remain at high
risk for recurrence after neoadjuvant chemoradiotherapy and surgery for esophageal or …

The 8th edition of the American Joint Committee on Cancer (AJCC) staging of epithelial
cancers of the esophagus and esophagogastric junction (EGJ) presents separate …

This primer for eighth edition staging of esophageal and esophagogastric epithelial cancers
presents separate classifications for the clinical (cTNM), pathologic (pTNM), and …

OBJECTIVE. The purpose of this article is to discuss the role of imaging in the management
of esophageal cancer. CONCLUSION. A multimodality-based approach to imaging is …

Answer questions and earn CME/CNE New to the eighth edition of the American Joint
Committee on Cancer (AJCC) Cancer Staging Manual for epithelial cancers of the …

Background Esophageal squamous cell cancer (ESCC) patients with the potentially
resectable disease most would experience relapse after surgery. Immunotherapy has been …

We report analytic and consensus processes that produced recommendations for pathologic
stage groups (pTNM) of esophageal and esophagogastric junction cancer for the …

Lung cancer care is rapidly changing with advances in genomic testing, the development of
next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy …

Objective: To determine the prognostic impact of pathologic lymph node (LN) status and
investigate risk factors of recurrence in esophageal squamous cell carcinoma (ESCC) …

We report data—simple descriptions of patient characteristics, cancer categories, and non–
risk-adjusted survival—for patients with pathologically staged cancer of the esophagus and …